The M4 Mac Mini Is the Best Value I've Found From Apple. And It's $100 Off Right Now for Prime Day
The M4 Mac Mini, Apple's smallest computer, is an easy recommendation for me since it's one of CNET's picks for the best desktop computers of 2025. It's also our go-to for the best cheap desktop alternative to a MacBook or iMac. Right now on Amazon, it's currently discounted by 9%, and Prime members can get an additional $46 off when you apply the on-page coupon. That's close to the lowest price we've seen on this powerful computer.
The M4 Mac Mini has been my best tech investment this year
The M4 Mac Mini plus Apple's current crop of USB-C Magic accessories makes for really nice portable computing solution. Add a portable monitor and you're set.
Josh Goldman/CNET
I've been joyfully surprised by M4 Mac Mini's value proposition and how wonderful it has been to work from a desk for me. As a freelance remote worker, I travel for at least 10 days every month, so I need a portable computer. Based on my lifestyle, I should be recommending the M4 MacBook Air. But it's the remaining 20 days of the month that I need to work harder than usual to work on new pitches, deliver approved stories, sort admin tasks, coordinate for hardware, research for my work and more. All of this requires immense organization and productivity, and the M4 Mac Mini has helped make my life easier.
The smallest Apple computer doesn't compromise on power. It features a 10-core CPU and 10-core GPU, 16GB of unified memory and a 256GB solid-state drive for storage. It's very powerful for a $599 machine and a bargain at $500. You likely won't be able to find similar reliability and power on a Windows machine for $500. I've tried and failed. And no, I'm not forgetting that the Mac Mini doesn't come with a display or a mouse and keyboard.
I paired my M4 Mac Mini with a 27-inch LG UltraGear monitor (currently down to $180) and a Logitech mouse and keyboard combo -- all for under $200. The UltraGear's big screen is quite useful for research and multitasking, as well as watching movies.
The M4 Mac Mini can be equally excellent for both home office and content creation needs. As CNET's Goldman wrote in his review, "The Mini can fit in your hand and be everything from an everyday home office computer to a full-on professional content-creation machine -- and an easily portable one at that -- with support for up to three 6K-resolution displays."
My buying recommendation
The M4 Mac Mini was launched in November 2024, and it's now available at a $100 discount, which is close to the lowest price we've seen. The small Apple computer offers a superb value proposition for remote workers and content creators alike. If you've been on the fence about getting a PC for home like me, I'd say pick up a M4 Mac Mini and see the difference for yourself.
Want to check out the competition? We've rounded up the best desktop computer deals from the likes of HP, Lenovo, Dell and, naturally, Apple. And if this desktop isn't up to your tastes, you can check out the best laptop deals.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Defi Tokens Are Soaring, Leaving Behind OG Coins Like LTC, BCH and XMR
Bitcoin's surge to an all time high on Thursday evoked mixed reactions from altcoins, with some outperforming the largest cryptocurrency by market cap and others lagging behind. And that's split along industry lines. Tokens associated with decentralized finance (DeFi) and those from layer-2 blockchains are outperforming as investors transition to a risk-on approach. Others, such as tron (TRX), bitcoin cash (BCH), litecoin (LTC) and monero (XMR) are, in comparison, barely moving. Even solana (SOL), the darling of the previous drive to record highs, seems to be taking a back seat, rising just 3.9% while the likes of sei (SEI), ethena (ENA) and optimism (OP) are celebrating gains of as much as 28%. "Altcoins are leading the pack in this latest rally," Thomas Perfumo, Kraken's global economist, said in an email. A drop in bitcoin dominance is "reinforcing a broad-based rally with altcoins leading the charge." During the 2017 and 2021 runs to record highs, bitcoin dominance — a measure of BTC's share of the total crypto market —rose rapidly. On Thursday's rally, it fell to 63.5% from 64%, indicating a shift in emphasis toward the altcoin market Crypto markets are cyclical by nature. They run without interruption 24 hours a day against a backdrop of high volatility and low liquidity which can create an emotional trading environment. In previous cycles, altcoins often moved in unison, rising as bitcoin consolidated and dropping en masse when it rose or fell. This time, however, seems different, possibly due to the increased participation of institutions in the the industry. The rise in DeFi tokens can be attributed to increasing institutional interest in ether (ETH), which could pave the way for a search for yield with firms battling to secure the highest returns. The same can be said for layer-2 networks. As institutions run into the Ethereum blockchain's issues with latency and efficiency, they may consider networks like Arbitrum that allow liquidity to flow from decentralized exchanges to staking protocols at a fast rate. That network's ARB token is up 15% in the past 24 hours. Still, Petr Kozyakov, CEO at payments firm Mercuryo, said the rise in altcoins will be short-lived. "While altcoins are also in the green with Ethereum spiking past the $3,000 mark, the underlying 'orange pill' narrative remains steadfastly in place," he said. "Bitcoin's growing status as a store of value is one that more and more big players and institutions are simply unable to ignore." That's not a narrative that finds much support from Arthur Hayes, the BitMEX founder turned fund manager. 'Get ready for a monster alt season,' he told his followers on X after predicting that ETH would reach $10,000 this cycle. If Hayes' prediction holds true, bitcoin could face short-term difficulty as liquidity will inevitably flow into the altcoin market as traders attempt to capture speculative gains. This could also be a hammer blow to the old-school crypto coins, which all lack major catalysts for a boost. Sign in to access your portfolio
Medscape
15 minutes ago
- Medscape
Revolutionizing Anesthesia Drug Management and Integrity
Stocking and restocking anesthesia carts is tedious and meticulous — and it's highly regulated. Anesthesiologists have direct and extensive access to controlled drugs in a hospital setting, particularly potent opioids and sedatives, which makes these processes vulnerable to the potential of abuse. Within the anesthesia ecosystem, the doctor has a partner in the stocking and restocking process, and that's the hospital pharmacy staff. This team has so much reporting to do: logging which medications were used by which operating teams and on which patients — data that ultimately get reported to the Drug Enforcement Administration. Errors in any part of the dispensing, stocking, and securing process could result in waste, fines, medication errors, or worse. Hospitals have been on the search for help. Several companies have focused on what's called RAIN RFID. The technology uses passive ultrahigh frequency waves to essentially perform the function of Bluetooth or Wi-Fi for short-range device communication. It's available to hospitals to help with everything from patient tracking to equipment security and compliance. For anesthesia departments, the company Intelliguard created what it calls the Mira Ecosystem. It's built on RAIN RFID and monitors each vial of medication through its entire journey, filling clinical, compliance, and supply chain functions. Tray Setups and Refills Are Quick, Easy, and Traceable According to Intelliguard, about 90% of its systems are currently deployed to serve anesthesia departments. When vials of medication arrive at the pharmacy, a technician applies the Mira tag to each vial, and immediately, the system begins tracking each individual one. 'Our system reads each of the 96-bit unique IDs and then associates those unique IDs with the medication. So now each of those IDs is associated with rocuronium, for example, and the company that made it, the serial number, and the expiration and the lot number,' said Paul Elizondo, Intelliguard's chief innovation officer. 'From then on, when our system sees that 96-bit unique ID, it associates it with the medication in a database. It displays that on the screen, and we know exactly what that medication is now.' Paul Elizondo The system tracks each vial of medication throughout its journey at the hospital, giving pharmacy managers and hospital administrators instant, real-time visibility into where each vial is and when. In terms of daily pharmacy tasks, making up medication trays for anesthesiologists is made nearly foolproof, reducing medication errors. 'The hospitals using our system will place these RFID-tagged medications into the tray, then they will place that tray into our enclosure,' said Elizondo. 'In 6 seconds, we read every single tag in that tray, and we let them know if that formula, if what's in the tray, matches the formulary to which they're building right at that time.' The system can also check to ensure there are no expired or recalled medications in the tray. The real-time savings come, though, when the anesthesiologist returns the tray at the end of the day. Rady Children's Hospital in San Diego is using this system. Performance improvement pharmacist Ann McKinstry explained some of the ways that she's seen return on investment gains. 'Pinpointing the medication location has allowed for a more rapid response to expiry, recalls, and patient care events,' McKinstry said. 'Inpatient pharmacy inventory is tightened by offering a streamlined data review to analyze usage and reducing waste by tightening supply on hand. In addition, RFID tags allow accurate controlled substance reconciliation by monitoring usage, waste, and replenishment down to the minute.' Real-Time Tracking of Medication Location Saves a Life Knowing exactly where your medications are on a real-time basis isn't just important: It can be a matter of life and limb. For example, if a patient with a deadly North American pit viper bite is rolled into your emergency department, as happened at a Bartow, Florida hospital at 1 AM on May 4 — you'd definitely want to know if you have antivenom on hand. Bartow was out. They reached out to Prodigy Health, distributor of specialty pharmaceuticals that supplies medicines to hospitals on a consignment basis. Prodigy runs a 24-hour switchboard and uses RAIN to gain visibility into what is being dispensed by each hospital. The antivenom was quickly located at a hospital in Lutz, Florida, one that had a RAIN RFID cabinet. The request was made, the antivenom was transferred, and the day was saved. Ty Dishman Before this technology, 'This process was manual and time-consuming. Now, with reliable data integrating into our system every 6 seconds, we're able to provide immediate, confident answers to customer inquiries about medication availability and delivery timelines,' said Ty Dishman, CEO of Prodigy Health. 'Instead of saying, 'I think it's there — let me check and call you back,' we can act quickly and efficiently, ensuring life-saving medications are mobilized without delay.' The Competitive Landscape RFID systems are nothing new in the healthcare environment. They're commonly used to track medical equipment and inventory, as well as in staff badging systems. Its use in medication management is fairly recent. Terso Solutions offers a similar suite to the Mira Ecosystem, with the exception of Intelliguard's direct-to-operating room tray system; Avery Dennison Medical and Healthcare provides a wide range of pharmaceutical labeling options, and some options include RFID.
Business Insider
15 minutes ago
- Business Insider
'Quiet Purge': Amazon (NASDAQ:AMZN) Warehouses Hit by Immigrant Labor Pushback
Online retail giant Amazon (AMZN) has a remarkable talent for getting large quantities of goods where they need to be in rapid fashion. But that talent did not manifest out of thin air. No, it is the result of thousands of workers at Amazon's warehouses and delivery operations that make it possible. And new reports say that it may have just been hit by a rather serious monkey wrench thrown into its works with the United States government's new attempt to run off illegal immigrants. Despite this, investors rallied around their choice of shopping venues and raised share prices fractionally in Monday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. One particular case focused on Frantzdy Jerome, originally from Haiti, who worked in an Ohio warehouse. Jerome had received kudos from Amazon several times; once in March, a supervisor called him out for his '…reliability, hard work and dedication to our team.' A second message just months later thanked Jerome for '…your flexibility and picking up the extra shifts.' But two weeks later, Jerome's work authorization was revoked, and his was not the only one. 'Hundreds' of others reportedly lost jobs at that Ohio warehouse, for the same reason: they were only allowed to work here because of a Biden-era program that has itself been revoked. While the impact is hitting Amazon, Amazon is hardly alone in this, reports note. A range of businesses—from auto parts plants to warehouses and beyond—are all taking hits from this policy. Alexa's Online Push Gets Pushed Back Meanwhile, Alexa is having some issues of its own. Four months ago, Amazon announced plans to bring out a web-based version of the Alexa virtual assistant to take on the likes of Grok and ChatGPT. But reports now suggest that bringing Alexa to the web proved a bigger challenge than expected, and now, Amazon needs more time to get the concept off the ground. In fact, new reports from late June say that there will be no way goes live any sooner than July 31. With the date now a floor rather than a ceiling, we may not see Amazon's attempt at landing a piece of the chatbot market before August, or even later. There were no specific reasons given for the deadline push, but the obvious does suggest itself: it is harder than you might think to engineer a chatbot. Is Amazon a Good Long-Term Investment? Turning to Wall Street, analysts have a Strong Buy consensus rating on AMZN stock based on 44 Buys and one Hold assigned in the past three months, as indicated by the graphic below. After a 16.76% rally in its share price over the past year, the average AMZN price target of $250.95 per share implies 10.51% upside potential.
